499 related articles for article (PubMed ID: 9262371)
21. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
22. In vitro affinity of piribedil for dopamine D3 receptor subtypes, an autoradiographic study.
Cagnotto A; Parotti L; Mennini T
Eur J Pharmacol; 1996 Oct; 313(1-2):63-7. PubMed ID: 8905329
[TBL] [Abstract][Full Text] [Related]
23. Characterization of (125)I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors.
Luedtke RR; Freeman RA; Boundy VA; Martin MW; Huang Y; Mach RH
Synapse; 2000 Dec; 38(4):438-49. PubMed ID: 11044891
[TBL] [Abstract][Full Text] [Related]
24. Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.
Reader TA; Molina-Holgado E; Dewar KM
Mol Neurobiol; 1992; 6(4):425-50. PubMed ID: 1285933
[TBL] [Abstract][Full Text] [Related]
25. Autoradiographic distribution of [3H]YM-09151-2, a high-affinity and selective antagonist ligand for the dopamine D2 receptor group, in the rat brain and spinal cord.
Yokoyama C; Okamura H; Nakajima T; Taguchi J; Ibata Y
J Comp Neurol; 1994 Jun; 344(1):121-36. PubMed ID: 7914895
[TBL] [Abstract][Full Text] [Related]
26. Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study.
Bancroft GN; Morgan KA; Flietstra RJ; Levant B
Neuropsychopharmacology; 1998 Apr; 18(4):305-16. PubMed ID: 9509498
[TBL] [Abstract][Full Text] [Related]
27. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis.
Rogoz R; Dziedzicka-Wasylewska M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):178-86. PubMed ID: 10208304
[TBL] [Abstract][Full Text] [Related]
28. Dopamine D2 receptors mapped in rat brain with [3H](+)PHNO.
Nobrega JN; Seeman P
Synapse; 1994 Jul; 17(3):167-72. PubMed ID: 7974199
[TBL] [Abstract][Full Text] [Related]
29. Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography.
Landwehrmeyer B; Mengod G; Palacios JM
Eur J Neurosci; 1993 Feb; 5(2):145-53. PubMed ID: 8261096
[TBL] [Abstract][Full Text] [Related]
30. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL
Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485
[TBL] [Abstract][Full Text] [Related]
31. [3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamen.
Xu J; Hassanzadeh B; Chu W; Tu Z; Jones LA; Luedtke RR; Perlmutter JS; Mintun MA; Mach RH
Synapse; 2010 Jun; 64(6):449-59. PubMed ID: 20175227
[TBL] [Abstract][Full Text] [Related]
32. Functional and autoradiographic characterization of dopamine D2-like receptors in the guinea pig heart.
Gómez Mde J; Rousseau G; Nadeau R; Berra R; Flores G; Suárez J
Can J Physiol Pharmacol; 2002 Jun; 80(6):578-87. PubMed ID: 12117307
[TBL] [Abstract][Full Text] [Related]
33. Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study.
Amenta F; Bronzetti E; Felici L; Ricci A; Tayebati SK
J Auton Pharmacol; 1999 Jun; 19(3):151-9. PubMed ID: 10511471
[TBL] [Abstract][Full Text] [Related]
34. Labeling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with [3H]7-OH-DPAT: a combined radioligand binding assay and immunochemical study.
Ricci A; Bronzetti E; Felici L; Greco S; Amenta F
J Neuroimmunol; 1998 Dec; 92(1-2):191-5. PubMed ID: 9916894
[TBL] [Abstract][Full Text] [Related]
35. In vitro receptor binding characteristics of the new dopamine D2 antagonist [125I]NCQ-298: methodological considerations of high affinity binding.
Jerning E; Malmberg A; Mohell N
J Recept Signal Transduct Res; 1995; 15(1-4):503-15. PubMed ID: 8903960
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterisation and autoradiographic localisation of a putative dopamine D3 receptor in the rat kidney.
Barili P; Ricci A; Baldoni E; Mignini F; Amenta F
Eur J Pharmacol; 1997 Oct; 338(1):89-95. PubMed ID: 9408008
[TBL] [Abstract][Full Text] [Related]
37. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
Sumiyoshi T; Stockmeier CA; Overholser JC; Thompson PA; Meltzer HY
Brain Res; 1995 May; 681(1-2):109-16. PubMed ID: 7552267
[TBL] [Abstract][Full Text] [Related]
38. Syntheses and pharmacological evaluation of two potent antagonists for dopamine D4 receptors: [11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C]methoxybenzamide.
Zhang MR; Haradahira T; Maeda J; Okauchi T; Kawabe K; Noguchi J; Kida T; Suzuki K; Suhara T
Nucl Med Biol; 2002 Feb; 29(2):233-41. PubMed ID: 11823129
[TBL] [Abstract][Full Text] [Related]
39. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
[TBL] [Abstract][Full Text] [Related]
40. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
Schetz JA; Chu A; Sibley DR
J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
